Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarworth Gp Regulatory News (HWG)

Share Price Information for Harworth Gp (HWG)

Share Price is delayed by 15 minutes
Get Live Data
124.80    0.20 (0.16%)
Bid:
124.20
Ask:
125.00
Spread: 0.80 (0.644%)
Market Cap: £405.85m
HWG Live PriceLast checked at - London Stock Exchange

Intraday Harworth Gp Share Chart

Form 8.5 (EPT/RI)

13 May 2010 10:16

RNS Number : 8500L
Numis Securities Limited
13 May 2010
 



FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

UK Coal Plc

Ordinary shares 1p

(c) Name of the party to the offer with which exempt principal trader is connected:

UK Coal Plc

(d) Date dealing undertaken:

12th May 2010

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary shares 1p

Purchase

20,000

52.30p

50.55p

Ordinary shares 1p

Sale

4,000

52.70p

52.70p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

NIL

NIL

 

NIL

NIL

NIL

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

NIL

NIL

NIL

NIL

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

NIL

NIL

 

NIL

NIL

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

N/A

 

 

 

Date of disclosure:

13th May 2010

Contact name:

Robin Ikel

Telephone number:

020 7260 1229

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERMMGMKLFDGGZG
Date   Source Headline
5th Oct 20233:42 pmRNSIssue of Shares and Total Voting Rights
5th Oct 20232:30 pmRNSDirector/PDMR Shareholding
4th Oct 20233:18 pmRNSIssue of Share and Total Voting Rights
25th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
20th Sep 202311:43 amRNSTotal Voting Rights
18th Sep 20233:56 pmRNSDirector/PDMR Shareholding
18th Sep 20233:35 pmRNSIssue of Share and Total Voting Rights'
12th Sep 20237:00 amRNSHalf Year Results for 6 months ended 30 June 2023
23rd Aug 20233:13 pmRNSIssue of Shares and Total Voting Rights
16th Aug 20233:37 pmRNSDirector/PDMR Shareholding
16th Aug 20233:31 pmRNSTotal Voting Rights
2nd Aug 202310:17 amRNSIssue of Shares and Total Voting Rights
27th Jul 20237:00 amRNSHalf Year Trading Update
18th Jul 20233:40 pmRNSDirector/PDMR Shareholding
18th Jul 20233:32 pmRNSIssue of Shares and Total Voting Rights
17th Jul 20239:00 amRNSBlock listing Interim Review
14th Jul 20239:30 amRNSBlock Listing Application
13th Jul 20239:00 amRNSDirector Declaration
19th Jun 202311:46 amRNSDirector/PDMR Shareholding
19th Jun 202311:40 amRNSIssue of Shares and Total Voting Rights
15th Jun 20239:45 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSCapital Markets Day
23rd May 202311:43 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
17th May 20238:54 amRNSDirector/PDMR Shareholding
17th May 20238:49 amRNSTotal Voting Rights
15th May 20232:05 pmRNSDirector/PDMR Shareholding
15th May 20231:55 pmRNSIssues of Shares and Total Voting Rights
10th May 20237:00 amRNS£35.8m of Investment Portfolio asset sales
2nd May 20239:00 amRNSDirector Declaration
18th Apr 20233:02 pmRNSDirector/PDMR Shareholding
18th Apr 20232:45 pmRNSIssue of Shares and Total Voting Rights
17th Apr 20231:49 pmRNSDirector/PDMR Shareholding
17th Apr 20231:05 pmRNSDirector/PDMR Shareholding
14th Apr 20234:27 pmRNSInvestor Presentation via Investor Meet Company
13th Apr 20237:00 amRNSPublication of ARA, Notice of AGM and NZC Pathway
28th Mar 20239:11 amRNSHolding(s) in Company
23rd Mar 20232:39 pmRNSDirector/PDMR Shareholding
16th Mar 20231:39 pmRNSDirector/PDMR Shareholding
16th Mar 202311:41 amRNSDirector/PDMR Shareholding
16th Mar 202311:33 amRNSTotal Voting Rights
14th Mar 20237:00 amRNSFull Year Results for year ended 31 December 2022
7th Mar 20234:35 pmRNSPrice Monitoring Extension
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20233:37 pmRNSDirector/PDMR Shareholding
16th Feb 20233:33 pmRNSTotal Voting Rights
31st Jan 20237:00 amRNSYear-end Trading Update
17th Jan 20234:21 pmRNSDirector/PDMR Shareholding
17th Jan 20233:57 pmRNSBlock Listing Cancellation & Block Listing Return
17th Jan 20233:53 pmRNSIssue of Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.